🇺🇸 FDA
Patent

US 9051379

Sp1 polypeptides, modified Sp1 polypeptides and uses thereof

granted A61KA61K38/17A61K47/64

Quick answer

US patent 9051379 (Sp1 polypeptides, modified Sp1 polypeptides and uses thereof) held by Fulcrum SP Ltd. expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Fulcrum SP Ltd.
Grant date
Tue Jun 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K38/17, A61K47/64, A61K47/6929, A61P